Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.
about
Animal Models of Uveal Melanoma: Methods, Applicability, and LimitationsQuantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRIAlbumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T1-T2 dual-mode contrast agents for accurate liver tumor imaging.Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns.ProCA1.GRPR: a new imaging agent in cancer detection.Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic MetastasesBiomolecular MRI reporters: Evolution of new mechanisms.Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.Magnetic resonance molecular imaging for non-invasive precision cancer diagnosisPolyurethane based organic macromolecular contrast agents (PU-ORCAs) for magnetic resonance imagingT- and T-weighted Magnetic Resonance Dual Contrast by Single Core Truncated Cubic Iron Oxide Nanoparticles with Abrupt Cellular Internalization and Immune EvasionMagnetic Resonance Imaging for Characterization of a Chick Embryo Model of Cancer Cell Metastases
P2860
Q26745595-578FB1DA-3CA8-4E6B-8443-2538F671E4A6Q33778968-431B8EB2-9680-415C-A44C-3D7941E6C748Q36291569-63AD3EC3-0BD0-4ED2-AE22-B152512B3328Q36314337-6BB00BB2-83E4-4A68-B96D-76A59185C62FQ36316226-C6BF648C-2333-4249-BFB1-337D3C932B8FQ40523481-67CB8A0D-81B6-42A7-A97D-78902AD7E043Q40983703-85B4CF3A-A9C6-4C1D-92F8-3C49425AD32DQ41131993-96B04893-2803-4286-AFB3-428AF3DECA63Q42760058-4C56E3D1-CD02-4146-86E3-76B93A5E7698Q46337911-0936B9AA-7E90-464D-8215-382FA0CAB6BCQ48178834-51D7F0C3-EB6B-4647-881B-BEA3739C087DQ55073008-42C506F9-9E82-4FB3-B014-815ED78CA1D3Q57152405-DC7A312E-916C-4176-86A2-2E73063A1BAEQ57369408-1776FE05-980E-4848-9F07-5BF41B178F2BQ58335465-B8C99976-5693-40C2-B579-59540958D99DQ58582204-90EA2444-6944-42C2-A9ED-F64FA52F498A
P2860
Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Protein MRI contrast agent wit ...... vity for liver cancer imaging.
@ast
Protein MRI contrast agent wit ...... vity for liver cancer imaging.
@en
type
label
Protein MRI contrast agent wit ...... vity for liver cancer imaging.
@ast
Protein MRI contrast agent wit ...... vity for liver cancer imaging.
@en
prefLabel
Protein MRI contrast agent wit ...... vity for liver cancer imaging.
@ast
Protein MRI contrast agent wit ...... vity for liver cancer imaging.
@en
P2093
P2860
P50
P356
P1476
Protein MRI contrast agent wit ...... ivity for liver cancer imaging
@en
P2093
Hans E Grossniklaus
Jenny J Yang
Jingjuan Qiao
Kendra Hubbard
Khan Hekmatyar
Mani Salarian
Robert C Long
P2860
P304
P356
10.1073/PNAS.1423021112
P407
P577
2015-05-13T00:00:00Z